Literature DB >> 27140200

Heteroresistance to colistin in Klebsiella pneumoniae is triggered by small colony variants sub-populations within biofilms.

Ana Silva1, Ana Margarida Sousa1, Diana Alves1, Anália Lourenço2, Maria Olívia Pereira3.   

Abstract

The emergence of Klebsiella pneumoniae multidrug-resistant strains paves the way to the re-introduction of colistin as a salvage therapy. However, recent planktonic studies have reported several cases of heteroresistance to this antimicrobial agent. The aim of this present work was to gain better understanding about the response of K. pneumoniae biofilms to colistin antibiotherapy and inspect the occurrence of heteroresistance in biofilm-derived cells. Biofilm formation and its susceptibility to colistin were evaluated through the determination of biofilm-cells viability. The profiling of planktonic and biofilm cell populations was conducted to assess the occurrence of heteroresistance. Colony morphology was further characterized in order to inspect the potential role of colistin in K. pneumoniae phenotypic differentiation. Results show that K. pneumoniae was susceptible to colistin in its planktonic form, but biofilms presented enhanced resistance. Population analysis profiles pointed out that K. pneumoniae manifest heteroresistance to colistin only when grown in biofilm arrangements, and it was possible to identify a resistant sub-population presenting a small colony morphology (diameter around 5 mm). To the best of our knowledge, this is the first report linking heteroresistance to biofilm formation and a morphological distinctive sub-population. Moreover, this is the first evidence that biofilm formation can trigger the emergence of heteroresistance in an apparently susceptible strain. © FEMS 2016. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Klebsiella pneumoniae; biofilm; colistin; heteroresistance; small colony variants

Mesh:

Substances:

Year:  2016        PMID: 27140200     DOI: 10.1093/femspd/ftw036

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  10 in total

1.  Deciphering Heteroresistance to Colistin in a Klebsiella pneumoniae Isolate from Marseille, France.

Authors:  Lucie Bardet; Sophie Baron; Thongpan Leangapichart; Liliane Okdah; Seydina M Diene; Jean-Marc Rolain
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

2.  Resistance and Heteroresistance to Colistin in Escherichia coli Isolates from Wenzhou, China.

Authors:  Wenli Liao; Jie Lin; Huaiyu Jia; Cui Zhou; Ying Zhang; Yishuai Lin; Jianzhong Ye; Jianming Cao; Tieli Zhou
Journal:  Infect Drug Resist       Date:  2020-10-09       Impact factor: 4.003

3.  Resistance and Heteroresistance to Colistin in Pseudomonas aeruginosa Isolates from Wenzhou, China.

Authors:  Jie Lin; Chunquan Xu; Renchi Fang; Jianming Cao; Xiucai Zhang; Yajie Zhao; Guofeng Dong; Yao Sun; Tieli Zhou
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

4.  In-Human Multiyear Evolution of Carbapenem-Resistant Klebsiella pneumoniae Causing Chronic Colonization and Intermittent Urinary Tract Infections: A Case Study.

Authors:  Michelle Kalu; Karen Tan; Marquerita Algorri; Peter Jorth; Annie Wong-Beringer
Journal:  mSphere       Date:  2022-05-09       Impact factor: 5.029

5.  Synergistic Activity of Colistin/Fosfomycin Combination against Carbapenemase-Producing Klebsiella pneumoniae in an In Vitro Pharmacokinetic/Pharmacodynamic Model.

Authors:  Jin Wang; Ji-Tong He; Yan Bai; Rui Wang; Yun Cai
Journal:  Biomed Res Int       Date:  2018-04-23       Impact factor: 3.411

Review 6.  Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities.

Authors:  Muhammad Asif; Iqbal Ahmad Alvi; Shafiq Ur Rehman
Journal:  Infect Drug Resist       Date:  2018-08-21       Impact factor: 4.003

7.  Colistin Heteroresistance in Klebsiella Pneumoniae Isolates and Diverse Mutations of PmrAB and PhoPQ in Resistant Subpopulations.

Authors:  Hae Suk Cheong; So Yeon Kim; Yu Mi Wi; Kyong Ran Peck; Kwan Soo Ko
Journal:  J Clin Med       Date:  2019-09-11       Impact factor: 4.241

8.  Synergistic activity of fosfomycin-meropenem and fosfomycin-colistin against carbapenem resistant Klebsiella pneumoniae: an in vitro evidence.

Authors:  Yamuna Devi Bakthavatchalam; Abirami Shankar; Dhiviya Prabaa Muthuirulandi Sethuvel; Kalaiarasi Asokan; Kalaiarasi Kanthan; Balaji Veeraraghavan
Journal:  Future Sci OA       Date:  2020-02-26

9.  Heteroresistance to Amikacin in Carbapenem-Resistant Klebsiella pneumoniae Strains.

Authors:  Feiyang Zhang; Qin Li; Jiawei Bai; Manlin Ding; Xiangjin Yan; Guangxi Wang; Baoli Zhu; Yingshun Zhou
Journal:  Front Microbiol       Date:  2021-12-02       Impact factor: 5.640

Review 10.  Antibiotic Heteroresistance in Klebsiella pneumoniae.

Authors:  Karolina Stojowska-Swędrzyńska; Adrianna Łupkowska; Dorota Kuczyńska-Wiśnik; Ewa Laskowska
Journal:  Int J Mol Sci       Date:  2021-12-31       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.